Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease gout
Symptom C0740394|hyperuricaemia
Sentences 4
PubMedID- 24225170 Potentially correctable persistent hyperuricaemia increases the risk of recurrent gout flares and there is also an association with increased cardiovascular morbidity .
PubMedID- 23741640 Febuxostat is orally administered a non-purine, selective inhibitor of xanthine oxidase being developed for the management of hyperuricaemia in patients with gout (zhu et al.
PubMedID- 24821702 hyperuricaemia) can lead to gout (2).
PubMedID- 21155617 The nice appraisal committee concluded that febuxostat be recommended as an option for the management of chronic hyperuricaemia in gout only for people who are intolerant to allopurinol or for whom allopurinol is contraindicated.

Page: 1